Trial intelligence / Profile preview

Shenfu injection for prevention of arrhythmia after PCI in acute STEMI

ChiCTR2200066918Phase 4Not yet recruiting

Sponsor
Shanghai Ninth People's Hospital
Start
Dec 2022
Countries
1
01

Overview

Phase 4, randomised trial of shenfu injection in acute ST-segment elevation myocardial infarction (STEMI) (2 arms), sponsored by Shanghai Ninth People's Hospital. Primary endpoint: Incidence of major arrhythmias during hospitalization. Planned start Dec 2022; status: not yet recruiting.

02

Drugs

shenfu injection
03

Conditions

acute ST-segment elevation myocardial infarction (STEMI)

Beyond the preview

Go deeper on ChiCTR2200066918.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2200066918.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call